Laird Norton Wetherby Wealth Management’s West Pharmaceutical WST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$535K Buy
+2,444
New +$535K 0.02% 533
2024
Q4
$1.03M Buy
3,135
+21
+0.7% +$6.88K 0.05% 333
2024
Q3
$935K Sell
3,114
-126
-4% -$37.8K 0.04% 378
2024
Q2
$1.07M Sell
3,240
-58
-2% -$19.1K 0.05% 334
2024
Q1
$1.31M Sell
3,298
-53
-2% -$21K 0.06% 298
2023
Q4
$1.18M Buy
3,351
+9
+0.3% +$3.17K 0.06% 317
2023
Q3
$1.25M Buy
3,342
+6
+0.2% +$2.25K 0.07% 286
2023
Q2
$1.28M Sell
3,336
-15
-0.4% -$5.74K 0.07% 287
2023
Q1
$1.16M Buy
3,351
+183
+6% +$63.4K 0.07% 304
2022
Q4
$746K Buy
3,168
+381
+14% +$89.7K 0.05% 393
2022
Q3
$686K Sell
2,787
-341
-11% -$83.9K 0.05% 384
2022
Q2
$946K Buy
3,128
+2,306
+281% +$697K 0.06% 309
2022
Q1
$338K Buy
822
+44
+6% +$18.1K 0.02% 671
2021
Q4
$365K Buy
778
+109
+16% +$51.1K 0.02% 636
2021
Q3
$284K Buy
669
+26
+4% +$11K 0.02% 712
2021
Q2
$231K Buy
+643
New +$231K 0.01% 798
2020
Q1
Sell
-2,272
Closed -$342K 750
2019
Q4
$342K Buy
2,272
+79
+4% +$11.9K 0.03% 499
2019
Q3
$311K Sell
2,193
-40
-2% -$5.67K 0.03% 535
2019
Q2
$279K Hold
2,233
0.03% 563
2019
Q1
$246K Sell
2,233
-15
-0.7% -$1.65K 0.03% 564
2018
Q4
$220K Hold
2,248
0.03% 560
2018
Q3
$278K Hold
2,248
0.03% 516
2018
Q2
$223K Buy
+2,248
New +$223K 0.03% 571
2018
Q1
Sell
-2,082
Closed -$205K 695
2017
Q4
$205K Hold
2,082
0.03% 596
2017
Q3
$200K Buy
+2,082
New +$200K 0.03% 576